These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18053615)

  • 1. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions.
    Kalra SP
    Peptides; 2008 Jan; 29(1):127-38. PubMed ID: 18053615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
    Kalra PS; Kalra SP
    Drugs Today (Barc); 2002 Nov; 38(11):745-57. PubMed ID: 12582458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches.
    Kalra SP
    Nutrition; 2008 Sep; 24(9):820-6. PubMed ID: 18725078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine?
    Genchi VA; D'Oria R; Palma G; Caccioppoli C; Cignarelli A; Natalicchio A; Laviola L; Giorgino F; Perrini S
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy.
    Kalra SP; Kalra PS
    Trends Pharmacol Sci; 2005 Oct; 26(10):488-95. PubMed ID: 16125798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine control of energy homeostasis: update on new insights.
    Kalra SP; Kalra PS
    Prog Brain Res; 2010; 181():17-33. PubMed ID: 20478430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term time-restricted feeding during the resting phase is sufficient to induce leptin resistance that contributes to development of obesity and metabolic disorders in mice.
    Oishi K; Hashimoto C
    Chronobiol Int; 2018 Oct; 35(11):1576-1594. PubMed ID: 30084652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
    Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
    Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenomenon of leptin resistance in seasonal animals: the failure of leptin action in the brain.
    Szczesna M; Zieba DA
    Domest Anim Endocrinol; 2015 Jul; 52():60-70. PubMed ID: 25863197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective insulin and leptin resistance in metabolic disorders.
    Könner AC; Brüning JC
    Cell Metab; 2012 Aug; 16(2):144-52. PubMed ID: 22883229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System.
    Russo B; Menduni M; Borboni P; Picconi F; Frontoni S
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases.
    Erichsen JM; Fadel JR; Reagan LP
    Neuropharmacology; 2022 Feb; 203():108877. PubMed ID: 34762922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Insight into the Interaction between Epigenetics and Leptin in Metabolic Disorders.
    Wróblewski A; Strycharz J; Świderska E; Drewniak K; Drzewoski J; Szemraj J; Kasznicki J; Śliwińska A
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31408957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain insulin and leptin signaling in metabolic control: from animal research to clinical application.
    Scherer T; Lehnert H; Hallschmid M
    Endocrinol Metab Clin North Am; 2013 Mar; 42(1):109-25. PubMed ID: 23391243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A spontaneous leptin receptor point mutation causes obesity and differentially affects leptin signaling in hypothalamic nuclei resulting in metabolic dysfunctions distinct from db/db mice.
    Piattini F; Le Foll C; Kisielow J; Rosenwald E; Nielsen P; Lutz T; Schneider C; Kopf M
    Mol Metab; 2019 Jul; 25():131-141. PubMed ID: 31076350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrinological and Clinical Aspects of Leptin.
    Yanik T; Durhan ST
    Mini Rev Med Chem; 2024; 24(9):886-894. PubMed ID: 37622709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for life-time.
    Kalra SP; Kalra PS
    EXS; 2006; (95):157-69. PubMed ID: 16383005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between leptin level, index of insulin resistance and the main indicators of carbohydrate and lipid metabolism in patients with varying degrees of obesity].
    Kryvenko VI; Fedorova OP; Hrinenko TIu; Kachan IS
    Wiad Lek; 2014; 67(2 Pt 2):341-3. PubMed ID: 25796865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.